The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

The mechanisms by which hepatitis C virus (HCV) induces chronic infection in the vast majority of infected individuals are unknown. Sequences within the HCV E1 and E2 envelope genes were analyzed during the acute phase of hepatitis C in 12 patients with different clinical outcomes. Acute resolving hepatitis was associated with relative evolutionary stasis of the heterogeneous viral population (quasispecies), whereas progressing hepatitis correlated with genetic evolution of HCV. Consistent with the hypothesis of selective pressure by the host immune system, the sequence changes occurred almost exclusively within the hypervariable region 1 of the E2 gene and were temporally correlated with antibody seroconversion. These data indicate that the evolutionary dynamics of the HCV quasispecies during the acute phase of hepatitis C predict whether the infection will resolve or become chronic.

[1]  A Cerino,et al.  Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross‐reactivity and immune‐mediated sequence variation , 1999, Hepatology.

[2]  A. Prince,et al.  Immunity in hepatitis C infection. , 1992, The Journal of infectious diseases.

[3]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[4]  J. Holland,et al.  Rapid evolution of RNA viruses. , 1987, Annual review of microbiology.

[5]  O. Laeyendecker,et al.  Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy , 1999, Journal of Virology.

[6]  N. Ogata,et al.  Lack of protective immunity against reinfection with hepatitis C virus , 1992 .

[7]  R. Purcell,et al.  Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. , 1986, Annals of internal medicine.

[8]  B. L. Welch.  THE SIGNIFICANCE OF THE DIFFERENCE BETWEEN TWO MEANS WHEN THE POPULATION VARIANCES ARE UNEQUAL , 1938 .

[9]  N. Kato,et al.  Hypervariable regions in the putative glycoprotein of hepatitis C virus. , 1991, Biochemical and biophysical research communications.

[10]  Matthew J. Brauer,et al.  Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. , 1991, Virology.

[11]  M. Sakamoto,et al.  A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. , 1993, Virology.

[12]  C. Ferrari,et al.  T‐cell response to structural and nonstructural hepatitis C virus antigens in persistent and self‐limited hepatitis C virus infections , 1994, Hepatology.

[13]  A. Weiner,et al.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution , 1992, Journal of virology.

[14]  K. Ishak,et al.  Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis , 1991, Hepatology.

[15]  N. Kato,et al.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus , 1993, Journal of virology.

[16]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[17]  Steven M. Wolinsky,et al.  Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.

[18]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[19]  S. Wain-Hobson.  Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. , 1992, Current topics in microbiology and immunology.

[20]  R. Purcell,et al.  A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. , 1996, Virology.

[21]  R. Purcell,et al.  Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee. , 1999, The Journal of infectious diseases.

[22]  M. Houghton,et al.  A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Schreier,et al.  Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. , 1995, Virology.

[24]  M. Shapiro,et al.  Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Purcell,et al.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. , 1991, The New England journal of medicine.

[26]  M. Massari,et al.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.

[27]  F. Iber,et al.  Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis , 1992 .

[28]  M. Houghton,et al.  A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan , 1991 .

[29]  M. Clementi,et al.  Evolution of Hypervariable Region 1 of Hepatitis C Virus in Primary Infection , 1998, Journal of Virology.

[30]  M. Nei,et al.  Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. , 1986, Molecular biology and evolution.

[31]  R H Purcell,et al.  At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Holland,et al.  RNA virus populations as quasispecies. , 1992, Current topics in microbiology and immunology.

[33]  H. Thomas,et al.  Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. , 1994, Gastroenterology.

[34]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[35]  H. Alter.  To C or not to C: these are the questions. , 1995, Blood.

[36]  Giorgio,et al.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.